Medical Companies

Industry: Pharmaceuticals, Biotechnology
Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in San Diego, California, and recently acquired a research and development laboratory adjacent to its manufacturing facility. In addition, the company has a pre-clinical research center in Kiev, Ukraine. Currently Phage has approximately 55 employees worldwide. The Company was formed to manufacture recombinant protein pharmaceuticals as either “bio-similar” drugs, or as new drug entities. The company has a portfolio of proprietary pegylated protein products that are rapidly advancing through pre-clinical ( www.phagebiotech.com )

Phage Biotechnology Corp
1635 Village Center Circle Suite 260
Las Vegas, Nevada 89134
USA

Tel: (702) 839-7270

Industry: Pharmaceuticals, Biotechnology
ARCA Discovery, Inc. is a privately held biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. The Company closed a $15 million Series A financing in February, 2006 led by Atlas Venture, Boulder Ventures and Peqout Capital Management. The Company’s first product is bucindolol, a third generation beta-blocker-vasodilator for advanced heart failure and other indications, that promises to be the first genetically-targeted cardiovascular drug. Bucindolol has extensive Phase III data and a unique Phase III DNA sub-study. Using this sub-study, ARCA’s founding scientists have confirmed genetic polymorphisms that interact with bucindolol’s unique pharmacology to modify patient ( www.arcadiscovery.com )

ARCA Discovery , Inc.
1200 17Th Street Suite 620
Denver, Colorado 80202
USA

Tel: (303) 893-1599
Fax: (303) 825-0883

Industry: Pharmaceuticals, Biotechnology
Akers Biosciences received notification from the Food and Drug Administration (FDA) on December 20, 2006 of the company’s ability to market the Breath Alcohol ® .02 Detection System (System). Akers received this marketing clearance through the FDA’s 510(k) submission process. The System pairs disposable breath alcohol testers with an easy-to-use electronic analyzer to objectively detect breath alcohol levels that are equal to or greater than .02 percent. The company will be initiating sales activities of the Breath Alcohol ® .02 Detection System primarily in industries overseen by the National Highway Traffic Safety Administration (NHTSA) as the device was reviewed and cleared for use by the US Department of Transportation (DOT) in October of ( www.akersbiosciences.com )

Akers Biosciences , Inc.
201 Grove Road
Thorofare, New Jersey 08086
USA

Tel: (856) 848-8698
Fax: (856) 848-0269

Industry: Pharmaceuticals, Biotechnology
Artisan Pharma is a U.S. biotechnology company formed in 2006 as a partnership between a group of Asian and Western investors led by NGN Capital and Asahi Kasei Pharma Corporation (AKP). Our lead product, ART 123, is a late-stage biologic drug candidate in-licensed from AKP. A new, separate, independent entity, Artisan has a mission to become a leading critical-care pharmaceutical company. By blending a high degree of skill with world-class R&D, corporate development and operational competencies, we aim to generate the maximum benefit to patients and the maximum value to our ( www.artisanpharma.net )

Artisan Pharma , Inc.
161 Worcester Road (Rt. 9)
Framingham, Massachusetts 01701
USA

Tel: (508) 663-2150
Fax: (508) 663-2151

Industry: Pharmaceuticals, Biotechnology
Prommune is a limited liability biotechnology company that was established to translate the results of laboratory research at the University of Nebraska Medical Center into products that improve the health of humans and animals. Prommune’s product focus is on the development of vaccines to infective pathogens as well as to small molecules not typically recognized by the immune system such as drugs of addiction and chemical toxins. The ability to induce immune responses to this variety of antigens is possible by vaccines that contain a unique and patented technology known as MIRADS, Molecular Immune Response Activator and Delivery System. ( www.prommune.net )

Prommune Inc.
4625 So 154Th Circle
Omaha, Nebraska 68137
USA

Tel: (402) 559-5353

Industry: Pharmaceuticals, Biotechnology
CellCyte Genetics is an emerging biotechnology leader in the discovery and development of breakthrough stem cell therapeutic products that are the first to facilitate stem cell delivery through the patient’s own circulatory/vascular system into specific organs. CellCyte’s therapeutics will be the first stem cell delivery compounds ever to enter FDA human clinical trials. ( www.cellcyte.com )

CellCyte Genetics Inc
P.O. Box 493
Kirkland, Washington 98083
USA

Tel: (206) 910-9244

Industry: Pharmaceuticals, Biotechnology
ReaMetrix Inc. provides the customer with unparalleled efficiency in product delivery for assay development and contract research. Through a unique business model, we are able to leverage the advantages of India’s scientific resources. Our employees in both the United States and India develop functional biology solutions for the most sophisticated detection platforms available. Because of our dual presence in San Carlos, California and Bangalore, India, we are able to draw on international resources while retaining local market expertise. ReaMetrix communicates our high commitment to quality through a highly developed standardization process, with documentation and audit trails for every ( www.reametrix.com )

ReaMetrix Inc
1585 Industrial Road
San Carlos, California 94070
USA

Tel: (650) 620-9253
Fax: (650) 620-0093

Industry: Pharmaceuticals, Biotechnology
GenUs BioSystems provides a time-saving and cost-effective way for scientists to utilize high-performance gene expression profiling — without investing in costly equipment or personnel. We use state-of-the-art bioarray technology to turn biological samples into practical genomic data – accurately and reproducibly. We offer a full range of services related to bioarray experimentation, such as gene expression profiling, RNA isolation, data analysis, pre- and post-experiment consulting, and RNA amplification from as little as 100 picograms of total RNA. And, all final reports are presented in a way that makes the information easy to use and apply to your research program without intensive data analysis. Find out how GenUs can put the power of genomic technology within your reach. ( www.genusbiosystems.com )

GenUs BioSystems Inc
1808 Janke Dr. Unit M
Northbrook, Illinois 60062
USA

Tel: (847) 291-9600
Fax: (847) 291-9903

Industry: Pharmaceuticals, Biotechnology
TECHNE Corporation (NASDAQ: TECH), incorporated in Minnesota in 1981, is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) located in Minneapolis, Minnesota and R&D Systems Europe Ltd. (RDSE) located in Abingdon, England. R&D Systems is a specialty manufacturer of biological products. It has two operating divisions: Hematology and Biotechnology. The Hematology Division develops and manufactures hematology controls, which are used in hospitals and clinical laboratories to check the accuracy of blood analysis ( www.techne-corp.com )

Techne Corp
614 McKinley Pl N E
Minneapolis, Minnesota 55413
USA

Tel: (612) 379-8854
Fax: (612) 379-6580